Online Only Articles |
1 Clinical Haematology/Bone Marrow Transplant Department, The Alfred, Melbourne, Victoria, Australia
2 Ronald Sawers Haemophilia Centre and Thrombosis Clinic, The Alfred, Melbourne, Victoria, Australia
3 Department of Anatomical Pathology, The Alfred, Melbourne, Victoria, Australia
4 Department of Infectious diseases, The Alfred, Melbourne, Victoria, Australia
5 Department of Diagnostic Genetics, LabPlus, Auckland City Hospital, Auckland, New Zealand
6 Victorian Cancer Cytogenetics Service, St Vincents Hospital, Victoria, Australia
Corresponding Author: Dr Mark A. Dawson, The Alfred, Commercial Road, Prahran, Melbourne, Victoria, Australia 3181, dawsonm{at}ausdoctors.net, Tel: +61392762000 Fax: +61392763021
Plasmablastic lymphoma is an AIDS related lymphoma that continues to have a poor prognosis despite significant advances in the management of HIV and lymphoproliferative diseases. In part this has been due to limited insights into the biology of this disease and the molecular mechanisms of oncogenesis. To date molecular abnormalities have not been described in plasmablastic lymphoma, and its aggressive clinical behaviour has been difficult to understand. We describe the first reported cytogenetic abnormality in plasmablastic lymphoma, an IgH/MYC translocation. It is also the first description of autologous stem cell transplantation in a patient with severe haemophilia A.
This article has been cited by other articles:
![]() |
A. M. Bogusz, A. C. Seegmiller, R. Garcia, P. Shang, R. Ashfaq, and W. Chen Plasmablastic Lymphomas With MYC/IgH Rearrangement: Report of Three Cases and Review of the Literature Am J Clin Pathol, October 1, 2009; 132(4): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Khoon Leong Chuah, Siok Bian Ng, L. Poon, and Wai Ming Yap Plasmablastic Lymphoma Affecting the Lung and Bone Marrow With CD10 Expression and t(8;14)(q24;q32) Translocation International Journal of Surgical Pathology, April 1, 2009; 17(2): 163 - 166. [Abstract] [PDF] |
||||